We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

MicroTissue: Transforming Drug Discovery
Industry Insight

We spoke to Ping Yeh, CEO of StemoniX, to learn more about the company and their mission. With an aim to accelerate and optimize drug discovery and development, StemoniX creates ‘ready-to-use’ microtissue plates that mimic the native organ tissue.

Read More

Overcoming Challenges in Single Cell Analysis
Industry Insight

BD Biosciences has developed a method with the potential to transform both single cell transcriptional profiling and high parameter proteomics

Read More

The Future of Toxicology: An Industry Case Study
Industry Insight

This article describes some new in vitro approaches to toxicology, as well as current initiatives, to facilitate the verification of methods and conclusions, and to enhance data sharing and scientific discovery.

Read More

Uncovering the Dark Matter of Microbiota
Industry Insight

We spoke to Dirk Löffert, Ph.D., CEO of Biomillenia, to learn about some of the challenges of isolating live bacterial species, and how microbiome-on-a-chip technology can help overcome some of these.

Read More

Unlocking The Full Potential of Organoids
Industry Insight

To learn about the importance of the extracellular matrix and some of the limitations of current organoid culture systems, we spoke to Colin Sanctuary, CEO and founder of QGel, a spin-out from EPFL.

Read More

In Vitro Toxicology Testing: Dismantling the Barriers via Collaboration
Industry Insight

Promoting the adoption of in vitro toxicity testing is an important undertaking, so we should strive to overcome the barriers preventing its widespread adoption. Already, collaborative efforts have made progress in this regard, and research advances are increasingly demonstrating the potential of in vitro biomimetic liver models.

Read More

In Vitro Toxicology Testing: The Barriers to Progression and Adoption
Industry Insight

The field of toxicology as a whole is at a crossroads where current and future technologies are enabling better predictions of toxicity before a substance is released for human consumption or exposure. While a few barriers remain, we are making progress towards overcoming them, from both technical and policy perspectives.

Read More

Cell-based Imaging and Screening Applications
Industry Insight

BioStatus develops and supplies products for cell-based imaging, cytometry and screening applications. We met with Roy Edward, Director at BioStatus during the High Content and Phenotypic Screening 2017 event to learn more.

Read More

A New Approach to Treating Hair Loss
Industry Insight

We spoke to Lee Buckler, President and CEO of RepliCel, to learn about the cellular mechanisms responsible for hair loss, and the potential that cell therapy could offer to treat the condition.

Read More

Cell Culture: Moving from 2D to 3D and Beyond
Industry Insight

To learn about the limitations of 2D cell culture models, the range of 3D tools available, and some of the advantages they can bring to researchers, we spoke to Dr. Richard Eglen, Vice President and General Manager of Corning Life Sciences.

Read More

 
Advertisement